fbpx

A Cancer Treatment Causes Side Effect of Night Vision

Research published in the Journal of Physical Chemistry Letters explained why photodynamic cancer therapy causes night vision in patients. Photodynamic therapy is a form of cancer treatment that uses light to destroy malignant cells. The interesting side effect patients have reported is night vision seen as silhouettes and outlines in the dark. Only now have researchers discovered the mechanics of this phenomenon.

The Mechanics of Night Vision

Photodynamic therapy involves injections of chlorin e6, a photosensitive compound. It’s the reaction between chlorin e6 and rhodopsin in the retinal photoreceptors rods that causes the apparent night vision to occur. Normally we see with visible light because of a compound in our eye called retinal being triggered by visible light. After triggering, retinal separates from rhodopsin, a light-sensitive protein in the retinas of our eyes, and an electrical signal is transmitted to our brain to interpret what we see. In the case of night vision seen by these cancer patients, infrared light combined with the chlorin e6 changes retinal in the same way it does under visible light conditions. “This explains the increase in night-time visual acuity,” chemist Antonio Monari, from the University of Lorraine in France tells CNRS (French National Centre for Scientific Research).

Using Molecular Simulation to Understand Chemical Reactions

The researchers used molecular simulation to model the movements of individual atoms as well as the breaking or creating of chemical bonds. It took several months of testing various simulations with millions of calculations before it was able to accurately model the chemical reaction caused by infrared radiation. “For our simulation we placed a virtual rhodopsin protein inserted in its lipid membrane in contact with several chlorin e6 molecules and water, or several tens of thousands of atoms,” Monari told CNRS.

Molecular simulation is a powerful tool and can help us better understand fundamental mechanisms. For example, it can help understand why certain DNA lesions are better repaired than others and help select the best therapeutic molecules by mimicking their interaction in a simulated model.

Reference: https://www.sciencealert.com/scientists-have-figured-out-how-a-cancer-treatment-gives-patients-night-vision

Featured Posts

SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read More
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read More
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read More
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read More
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more